American coronavirus: Wearing masks could save at least 10,000 people from death from Covid-19 by August, model predicts

0
12
FDA to assess Pfizer's request to clear Covid-19 vaccine for children ages 12 to 15 `` as quickly as possible, '' acting commissioner says


[]).push(function () { viAPItag.display(“vi_1088641796”) }) || []).push(function () { viAPItag.display(“vi_1088641796”) })

In the worst-case scenario, in which fully vaccinated people return to pre-pandemic mobility levels, the forecast drops to 697,573, according to the IHME forecast. The projection takes into account the rate of vaccine distribution as well as the worrying spread of more transmissible variants.

All 50 states are on track to open vaccines to Americans 16 and older starting April 19. Although increasing vaccinations is an important step in beating the virus, health experts warn the country is in a race against variants, like B.1.1.7 first identified in the UK, which have the potential to cause a further increase in cases.

The United States reported at least 80,157 new cases on Friday, on the third day in a row and on the fourth day of last week, the United States reported at least 75,000 or more cases, according to Johns Hopkins University. Overall, more than 561,000 people have died from coronavirus to date, according to the count.

Vaccines are an effective tool against the spread of the virus, but they are not perfect and should be supplemented with precautions such as wearing masks and avoiding gatherings indoors, Dr Anthony Fauci said.
“I don’t think I would go – even if I’m vaccinated – to a covered, crowded place where people aren’t wearing masks,” the director of the National Institute of Allergy and Infectious Diseases told Business Insider .

Pfizer seeks to extend vaccination to Americans as young as 12

To date, the youngest Americans eligible for vaccines are 16 years old.

But on Friday, acting Food and Drug Administration commissioner Dr Janet Woodcock said the agency would assess Pfizer’s request to extend the vaccine’s emergency use authorization “as quickly as possible”. Covid-19 from the drug maker to people aged 12 to 15.

“Although the FDA cannot predict how long our assessment of the data and information will take, we will review the request as quickly as possible using our in-depth, science-based approach.” Woodcock said on Twitter.

The pharmaceutical company said it would seek similar rulings from other authorities around the world in the coming days.

“These claims are based on data from the pivotal phase 3 trial in adolescents 12 to 15 years of age with or without prior evidence of SARS-CoV-2 infection, which demonstrated 100% efficacy and Robust antibody response after vaccination with the COVID-19 Vaccine, ”Pfizer said in a statement.

Covid-19 cases and hospitalizations on the rise, CDC director says

Meanwhile, Covid-19 cases and hospitalizations are increasing – especially among younger people – as deaths decline, Dr Rochelle Walensky, director of the U.S. Centers for Disease Control and Prevention, said on Friday during a White House briefing.

An increase in cases and emergency room visits is seen among young adults, many of whom have not been vaccinated, she said.

Five states account for 43% of new Covid-19 cases in the country last weekFive states account for 43% of new Covid-19 cases in the country last week

People aged 18 to 25, 26 to 54 and 55 to 64 are having an increasing number of emergency room visits, she said, while people aged 65 and older are having visits to the emergency room. decline, “probably demonstrating the important impact of vaccination in protecting against diseases requiring hospitalization.” “

Walensky said that although these are national statistics, the trends are magnified in some parts of the country.

With the spread of the more transmissible B.1.1.7 variant as well as the lower proportion of young people vaccinated, the surge that experts fear could have a dramatic impact on young Americans.

“We have to think of the B.1.1.7 variant as almost a whole new virus,” said Dr Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine earlier this week. “It acts differently than anything we’ve seen before, in terms of transmissibility, in terms of affecting young people, so we have to take that very seriously. “

Concerns about side effects

In Colorado, following reports of adverse reactions, three drive-through vaccination sites will stop offering the Johnson & Johnson vaccine on Saturday.

The venues are Dick’s Sporting Goods Park in Commerce City, Broadmoor World Arena in Colorado Springs and Colorado State Fairgrounds in Pueblo, according to a press release from Centura Health.

The healthcare network reiterated CDC guidelines that the Johnson & Johnson vaccine is safe and effective, but said the decision was made due to the vaccine shortage across the country and cases of adverse reactions which occurred during a vaccination event at Dick’s Sporting Goods Park earlier this week.

Biden Extends Deadline for All U.S. Adults to Be Eligible for Covid Vaccine to April 19Biden Extends Deadline for All U.S. Adults to Be Eligible for Covid Vaccine to April 19

The Dick’s Sporting Goods Park vaccination site had to close early Wednesday after at least 11 of the more than 1,700 people receiving the Johnson & Johnson vaccine experienced side effects.

However, officials in Wake County, North Carolina, plan to resume administration of the Johnson & Johnson vaccine on Monday, after taking a break on Thursday when 18 people at PNC Arena had “mild to severe reactions immediately.” after their vaccinations.

The move follows an extensive internal review that further supports the findings of the Centers for Disease Control and Prevention and the North Carolina Department of Health and Human Services. The findings are consistent with those of other similar events across the country, which do not indicate any issues of concern, ”he said in a statement.

The CDC, in a statement to CNN, said it was aware of the various J&J vaccine incidents reported in Iowa, Colorado, Georgia and North Carolina.

At this time, the CDC and the FDA “are not recommending that health departments stop administering batches of COVID-19 vaccine,” the statement said. “The CDC performed batch analyzes of the vaccine and found no cause for concern. ”

Lauren Mascarenhas, Dave Alsup, Betsy Klein, Ben Tinker, Theresa Waldrop, Naomi Thomas, Alta Spells, Jeremy Harlan, Amanda Sealy, and Amanda Watts contributed to this report.

[]).push(function () { viAPItag.display(“vi_1088641796”) }) || []).push(function () { viAPItag.display(“vi_1088641796”) })



LEAVE A REPLY

Please enter your comment!
Please enter your name here